A number of other research analysts also recently commented on NH. Zacks Investment Research downgraded NantHealth from a buy rating to a hold rating in a report on Thursday, August 15th. Cowen set a $1.00 price objective on NantHealth and gave the stock a buy rating in a report on Monday, August 26th.
NASDAQ:NH opened at $1.07 on Tuesday. The firm has a 50-day moving average of $0.87 and a two-hundred day moving average of $0.66. The stock has a market cap of $130.53 million, a P/E ratio of -0.61 and a beta of 1.54. NantHealth has a 1-year low of $0.45 and a 1-year high of $1.96.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Tower Research Capital LLC TRC lifted its holdings in NantHealth by 778.8% during the 3rd quarter. Tower Research Capital LLC TRC now owns 45,988 shares of the company’s stock worth $33,000 after buying an additional 40,755 shares during the last quarter. Miracle Mile Advisors LLC grew its position in shares of NantHealth by 154.2% in the 2nd quarter. Miracle Mile Advisors LLC now owns 75,000 shares of the company’s stock worth $39,000 after acquiring an additional 45,500 shares in the last quarter. Finally, Paloma Partners Management Co increased its holdings in shares of NantHealth by 436.1% in the 2nd quarter. Paloma Partners Management Co now owns 91,100 shares of the company’s stock valued at $48,000 after acquiring an additional 74,108 shares during the last quarter. Hedge funds and other institutional investors own 2.84% of the company’s stock.
NantHealth, Inc, together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice.
Featured Story: What does relative strength index mean?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.